BackPyxis Oncology Overview
Pyxis Oncology Inc

Pyxis Oncology Target Price

See Pyxis Oncology's analyst price targets ($7) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.89

Average Target Price

$7.0079.9% upside

1 analysts in the last 4 months

High: $7 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-02Leerink PartnersJeffrey La Rosa$779.9% upsideOpen
2026-05-05WedbushRobert Driscoll$654.2% upsideOpen
2025-12-18RBC CapitalLeonid Timashev$528.5% upsideOpen
2025-11-24StephensSudan Loganathan$8105.7% upsideOpen
2025-11-04GuggenheimBradley Canino$779.9% upsideOpen
2025-09-04Guggenheim$528.5% upsideOpen
2024-08-16H.C. WainwrightSwayampakula Ramakanth$779.9% upsideOpen
2024-08-07Stifel NicolausBradley Canino$10157.1% upsideOpen
2024-05-07JefferiesFarzin Haque$10157.1% upsideOpen

Pyxis Oncology (PYXS) FAQ

As of the most recent data, PYXS shows a target price of $7. Scroll down for historical charts and peer comparison views.

If Pyxis Oncology moved to the average analyst target of $7, shares would be roughly 79.9% higher than $3.89. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Pyxis Oncology's earnings trajectory.

Besides this target price page, Stockcircle has Pyxis Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $7) with ownership activity and broader fundamentals.

Pyxis Oncology's target price is $7; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.